Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,165.08
(
0.80%
)
US TECH 100
26,538.40
(
1.85%
)
Dow Jones
49,247.66
(
-0.13%
)
Brent Oil
100.66
(
0.00%
)
Bitcoin
78,919.08
(
1.67%
)
News Focus
News Focus
Post# of 822953
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

LearningEveryTrade

Send PM Follow Ignore
Followers 21
Posts 1402
Boards Moderated 0
Alias Born 03/03/2021

LearningEveryTrade

Re: HyGro post# 521997

Saturday, 10/15/2022 12:47:07 AM

Saturday, October 15, 2022 12:47:07 AM

Post# of 822953
US is dominant market because of very high prices, so, the numbers are skewed a bit. Your a numbers guy, you know that.

Nonocure does have 'device' approved. Revenue, yes. Hence, able to fund more trials. NWBO will take the same route when they have the impending approval and revenue generation over the coming years.

The TTF trials will be interesting to see if they hurt healthy cells division.

ASM= Actively Supporting Management

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent NWBO News
More NWBO News